Revenue Recognition (Tables)

6 Months Ended

Jun. 30, 2025

Revenue Recognition

Schedule of disaggregation of revenues by payer types

	Three months ended				Six months ended
	June 30,				June 30,
	2025		2024		2025		2024
	(in thousands)
Insurance carriers	$	516,987	$	384,128	$	989,635	$	725,156
Laboratory partners		22,169		22,254		43,001		42,530
Patients		7,444		6,969		15,795		13,406
Total revenues	$	546,600	$	413,351	$	1,048,431	$	781,092

Schedule of total revenue by geographic area

	Three months ended				Six months ended
	June 30,				June 30,
	2025		2024		2025		2024
	(in thousands)
United States	$	537,801	$	404,872	$	1,030,107	$	764,285
Americas, excluding U.S.		1,571		1,601		3,263		3,082
Europe, Middle East, India, Africa		5,408		5,439		11,457		10,617
Asia Pacific and Other		1,820		1,439		3,604		3,108
Total revenues	$	546,600	$	413,351	$	1,048,431	$	781,092

Schedule of beginning and ending balances of accounts receivable and deferred revenues

	Balance at
	June 30,		December 31,
	2025		2024
	(in thousands)
Assets:
Accounts receivable, net	$	309,224	$	314,165
Liabilities:
Deferred revenue, current portion	$	21,560	$	19,754
Deferred revenue, long-term portion (1)		16,492		16,838
Total deferred revenues	$	38,052	$	36,592

Schedule of changes in the balance of deferred revenues

	Balance at
	June 30,
	2025			2024
	(in thousands)
Beginning balance	$	36,592	$	35,740
Increase in deferred revenues		20,369		14,826
Revenue recognized during the period included in deferred revenues at the beginning of the period		(14,904)		(9,646)
Revenue recognized from performance obligations satisfied within the same period		(4,005)		(4,137)
Ending balance	$	38,052	$	36,783